Results

Total Results: 66 records

Showing results for "Practice Guideline for the Treatment of Patients with Eating Disorders (NGC)".

  1. srdrplus.ahrq.gov/published_projects?page=10
    November 22, 2023 - or intermediate outcomes) for clinically significant outcomes in patients with OSA, effectively assessing … The SR will attempt to describe heterogeneity of treatment effects in terms of diversity of patient populations … and other providers of care for patients with OSA, healthcare policy makers, and patients. … The SR will attempt to describe heterogeneity of treatment effects in terms of diversity of patient populations … and other providers of care for patients with OSA, healthcare policy makers, and patients.
  2. srdrplus.ahrq.gov/published_projects?page=51
    June 23, 2021 - in the Pharmacologic Treatment of Adult Depression: An update of the 2007 Comparative Effectiveness … the treatment of depressive disorders, including variations of effects in patients with accompanying … the treatment of acute-phase MDD. … the treatment of dysthymia and subsyndromal depression. … for treatment evaluation in the United States, both in order to summarize the current state of the science
  3. srdrplus.ahrq.gov/published_projects?page=40
    October 31, 2022 - Recently Published Projects Search for more Projects Published on June 27, 2021 Systematic Review ofTreatments for Basal Cell and Squamous Cell Carcinoma of the Skin 69 Citations • 2 Key Questions • 69 … care for children with indications for tonsillectomy, and for families making treatment decisions. … This report supplies practitioners and researchers up-to-date information about the current state of … evidence and assesses the quality of studies that aim to determine the outcomes and safety of tonsillectomy
  4. srdrplus.ahrq.gov/published_projects?page=8
    May 30, 2023 - ) treatment of LTBI with pharmacotherapy regimens that are currently recommended by the Centers for Disease … with pulmonary fibrotic lesions; it may overestimate the benefits of treatment for populations with … Contemporary treatment studies have not included placebo arms; benefits and harms of newer treatmentsTreatment of LTBI with recommended regimens reduces the risk of progression to active TB. … and patients.
  5. srdrplus.ahrq.gov/usage
    and is otherwise in compliance with the license. … For more information, see the Agency for Healthcare Research and Quality (AHRQ) Privacy Policy ( … the official views of the SRDR team, AHRQ, the National Institutes of Health (NIH), HHS, or theThe SRDR support team is not required to respond to any comment, particularly ones that deal with … Thank you for taking the time to review our comment policy.
  6. srdrplus.ahrq.gov/published_projects?page=13
    September 14, 2022 - READ MORE Published on September 12, 2022 The lack of evidence for PET or PET/CT surveillance of patients … In patients with chronic pain, what is the effectiveness of nonopioid pharmacologic agents versus placebo … In patients with chronic pain, what is the comparative effectiveness of nonopioid pharmacologic agents … In patients with chronic pain, what are the risks of nonopioid pharmacologic agents for harms including … patient comorbidities, (4) dose of medication used, (5) duration of treatment, and (6) dose titration
  7. srdrplus.ahrq.gov/published_projects?page=21
    June 27, 2021 - Last updated on June 27, 2021 Objectives: 12% of patients with AML harbor mutation at Isocitrate dehydrogenase … Evidence from studies of persons seeking or referred for treatment for substance use or with clinical … treatment, when presenting with signs or symptoms of drug use, when screened for drug use in primary … Naltrexone and methadone/buprenorphine therapy were also associated with increased likelihood of retention … Evidence was lacking on effectiveness of treatments for opioid use disorder related to prescription drug
  8. srdrplus.ahrq.gov/published_projects?page=5
    October 12, 2023 - Purpose: To systematically review evidence for the effectiveness and harms of screening and treatmentFor studies evaluating the benefits and harms of treatment, we included RCTs of lipid-lowering medications … of various lipid-lowering treatments for FH including pharmacotherapy, behavioral counseling, and dietary … of various lipid lowering treatments for multifactorial dyslipidemia. … With the exception of statins evaluated in the FH population, the bodies of evidence for any specific
  9. srdrplus.ahrq.gov/published_projects?page=46
    June 23, 2021 - , and trials of fluorescent cystoscopy, intravesical therapy, and radiation therapy for NMIBC that evaluated … Intravesical therapy was more effective than no intravesical therapy for reducing risk of bladder cancer … outcomes in patients with T1G3 cancers. … Urinary biomarkers miss a substantial proportion of patients with bladder cancer, and additional research … BCG is the only intravesical therapy shown to be associated with decreased risk of bladder cancer progression
  10. srdrplus.ahrq.gov/published_projects?page=22
    June 27, 2021 - Recently Published Projects Search for more Projects Published on June 27, 2021 Automated-Entry Patient … Use of Chloroquine and Hydroxychloroquine for Prophylaxis and Treatment of COVID-19 24 Citations • 1 … used alone or when combined with azithromycin for the prophylaxis and treatment of COVID-19. … READ MORE Published on June 27, 2021 Nonopioid Pharmacologic Treatments for Chronic Pain 180 Citations … effectiveness and comparative effectiveness of nonopioid pharmacologic agents in patients with specific
  11. srdrplus.ahrq.gov/published_projects?page=38
    June 27, 2021 - evidence for the effectiveness of environmental sanitary measures on the prevalence of active trachoma … of patients with onchocerciasis (2016) 3 Citations • 1 Key Questions • 3 Extraction Forms Project created … and treatment of onchocerciasis. … for prevention and treatment of onchocercal ocular lesions in communities co-endemic for onchocerciasis … objective of this review was to assess the effects of corticosteroids on visual recovery in eyes with
  12. srdrplus.ahrq.gov/published_projects?page=42
    June 27, 2021 - fiber literature for the purposes of conducting a meta-analysis or systematic review. … READ MORE Published on June 27, 2021 The shortcomings of cluster-randomized controlled trials for the … Such disparities may be even more pronounced between certain groups of patients with SMI, differing by … the benefits and harms of second-generation antidepressants (SGAs), psychological treatment options … and as second-step interventions for patients with MDD who did not achieve remission after a first treatment
  13. srdrplus.ahrq.gov/published_projects?page=49
    June 23, 2021 - the treatment of adults with type 2 diabetes; Data Sources: We searched the MEDLINE, Embase, and Cochrane … choices for patients. … The balance of benefits to harms is favorable for providing prophylaxis to these patients and to extend … READ MORE Published on June 23, 2021 Treatments for Ankyloglossia and Ankyloglossia with Concomitant … We systematically the reviewed the literature on surgical and nonsurgical treatments for infants and
  14. srdrplus.ahrq.gov/published_projects?page=23
    June 27, 2021 - of therapy for noninvasive nonpharmacological treatment for selected chronic pain conditions. … Evidence on harms was limited, with no evidence suggesting increased risk for serious treatment-related … Chronic low back pain: Psychological therapies were associated with small improvements compared with … course of therapy for specific chronic pain conditions. … beyond the immediate post-treatment period is needed, particularly for conditions other than low back
  15. srdrplus.ahrq.gov/published_projects?page=33
    June 27, 2021 - Recently Published Projects Search for more Projects Published on June 27, 2021 Treatments for Adults … For drug therapy, the majority of the head to head evidence was on older SGAs, with sparse data on SGAs … Quality of life was improved more with cognitive behavioral therapy and early interventions for FEP than … READ MORE Published on June 27, 2021 Systematic Review on the Use of Cryotherapy Versus other Treatments … events profile of cryotherapy for the treatment of basal cell carcinoma compared to other therapeutic
  16. srdrplus.ahrq.gov/published_projects?page=45
    June 23, 2021 - This review examines the evidence on the comparative benefits and harms of noninvasive treatments for … Most trials enrolled patients with pain symptoms of at least moderate intensity (e.g., >5 on a 0- to … For chronic low back pain, effective therapies versus placebo, sham, no treatment, usual care, or wait … Few trials evaluated the effectiveness of treatments for radicular low back pain, but the available evidence … of treatments, effectiveness of treatments for radicular low back pain, and effectiveness on outcomes
  17. srdrplus.ahrq.gov/published_projects?page=11
    October 25, 2022 - versus placebo or no treatment, recently approved medical therapies versus older therapies, and selective … Evidence on the accuracy of instruments for identifying patients at higher risk of glaucoma was limited … versus placebo or no treatment, recently approved medical therapies versus older therapies, and selective … Evidence on the accuracy of instruments for identifying patients at higher risk of glaucoma was limited … to patients with marked dyslipidemia.
  18. srdrplus.ahrq.gov/published_projects?page=19
    June 27, 2021 - therapy in patients with specific types of acute pain, including effects on pain, function, quality … for the acute treatment of episodic migraine in adults. … Compared with placebo, several non-pharmacologic treatments may improve various measures of pain, including … A number of acute treatments for episodic migraine exist with varying degrees of evidence for effectiveness … The evidence base for many other interventions for acute treatment, including opioids, remains limited
  19. srdrplus.ahrq.gov/published_projects?page=7
    June 13, 2023 - comparative effectiveness and harms of external beam radiation therapy (EBRT) for palliative treatmentwith pulmonary fibrotic lesions; it may overestimate the benefits of treatment for populations with … Contemporary treatment studies have not included placebo arms; benefits and harms of newer treatmentswith pulmonary fibrotic lesions; it may overestimate the benefits of treatment for populations with … Contemporary treatment studies have not included placebo arms; benefits and harms of newer treatments
  20. srdrplus.ahrq.gov/blog
    August 26, 2021 - At the time, I was not particularly mindful of the andragogical utility of any … of the tools I... … after the review is complete, and sharing the data with others (including other … systematic reviewers, clinical guideline developers, healthcare professionals, patients … sharing the results of systematic reviews.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: